Survival in Systemic Sclerosis With Pulmonary Arterial Hypertension Has Not Improved in the Modern Era

Background The impact of modern therapy on survival in pulmonary arterial hypertension (PAH) associated with systemic sclerosis (SSc) is not clear. We sought to determine associations among commonly used clinical and hemodynamic variables, treatment, and long-term survival in PAH associated with SSc...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Chest 2013-10, Vol.144 (4), p.1282-1290
Hauptverfasser:	Rubenfire, Melvyn, MD, Huffman, Mark D., MD, MPH, Krishnan, Sangeetha, MS, Seibold, James R., MD, Schiopu, Elena, MD, McLaughlin, Vallerie V., MD, FCCP
Format:	Artikel
Sprache:	eng
Schlagworte:	Antihypertensive Agents - therapeutic use Cohort Studies Epoprostenol - therapeutic use Familial Primary Pulmonary Hypertension Female Humans Hypertension, Pulmonary - complications Hypertension, Pulmonary - drug therapy Male Middle Aged Pulmonary/Respiratory Retrospective Studies Scleroderma, Systemic - complications Scleroderma, Systemic - mortality Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!